These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 33178392)

  • 1. Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome.
    Lin F; Ichim TE; Pingle S; Jones LD; Kesari S; Ashili S
    World J Stem Cells; 2020 Oct; 12(10):1067-1079. PubMed ID: 33178392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases.
    Tsuchiya A; Takeuchi S; Iwasawa T; Kumagai M; Sato T; Motegi S; Ishii Y; Koseki Y; Tomiyoshi K; Natsui K; Takeda N; Yoshida Y; Yamazaki F; Kojima Y; Watanabe Y; Kimura N; Tominaga K; Kamimura H; Takamura M; Terai S
    Inflamm Regen; 2020; 40():14. PubMed ID: 32582401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Umbilical Cord-derived Mesenchymal Stem Cells for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS).
    Lanzoni G; Linetsky E; Correa D; Alvarez RA; Marttos A; Hirani K; Cayetano SM; Castro JG; Paidas MJ; Efantis Potter J; Xu X; Glassberg M; Tan J; Patel AN; Goldstein B; Kenyon NS; Baidal D; Alejandro R; Vianna R; Ruiz P; Caplan AI; Ricordi C
    CellR4 Repair Replace Regen Reprogram; 2020; 8():. PubMed ID: 34164564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives on mesenchymal stem/progenitor cells and their derivates as potential therapies for lung damage caused by COVID-19.
    Klimczak A
    World J Stem Cells; 2020 Sep; 12(9):1013-1022. PubMed ID: 33033561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 immunopathology with emphasis on Th17 response and cell-based immunomodulation therapy: Potential targets and challenges.
    Pourgholaminejad A; Pahlavanneshan S; Basiri M
    Scand J Immunol; 2022 Feb; 95(2):e13131. PubMed ID: 34936112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stromal cells as potential immunomodulatory players in severe acute respiratory distress syndrome induced by SARS-CoV-2 infection.
    Mallis P; Michalopoulos E; Chatzistamatiou T; Stavropoulos-Giokas C
    World J Stem Cells; 2020 Aug; 12(8):731-751. PubMed ID: 32952855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulation of Mesenchymal Stem Cells in Acute Lung Injury: From Preclinical Animal Models to Treatment of Severe COVID-19.
    Li JP; Wu KH; Chao WR; Lee YJ; Yang SF; Chao YH
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of Mesenchymal Stem Cells: A Potential Adjuvant Therapy for COVID-19.
    Zhu Y; Geng S; Li Q; Jiang H
    Front Bioeng Biotechnol; 2020; 8():557652. PubMed ID: 33224928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potency of Mesenchymal Stem Cell and Its Secretome in Treating COVID-19.
    Chouw A; Milanda T; Sartika CR; Kirana MN; Halim D; Faried A
    Regen Eng Transl Med; 2022; 8(1):43-54. PubMed ID: 33723519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of Mesenchymal Stem Cell Therapy for COVID-19: A Mini Review.
    Li J; Wang X; Li N; Jiang Y; Huang H; Wang T; Lin Z; Xiong N
    Curr Gene Ther; 2020; 20(4):285-288. PubMed ID: 32867652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cell therapy for COVID-19.
    Sengul F; Ozturk B; Vatansev H
    Am J Stem Cells; 2021; 10(5):79-89. PubMed ID: 35103115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells: a new front emerges in coronavirus disease 2019 treatment.
    Raza SS; Khan MA
    Cytotherapy; 2022 Aug; 24(8):755-766. PubMed ID: 35880307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells and their derived exosomes for the treatment of COVID-19.
    Hou XY; Danzeng LM; Wu YL; Ma QH; Yu Z; Li MY; Li LS
    World J Stem Cells; 2024 Apr; 16(4):353-374. PubMed ID: 38690515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Clinical Application of Mesenchymal Stem Cells in the Treatment of Severe COVID-19 Patients: Review.
    Adugna DG
    Stem Cells Cloning; 2021; 14():71-80. PubMed ID: 34785907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could Mesenchymal Stem Cell-Derived Exosomes Be a Therapeutic Option for Critically Ill COVID-19 Patients?
    Gardin C; Ferroni L; Chachques JC; Zavan B
    J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32858940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects.
    Abdelgawad M; Bakry NS; Farghali AA; Abdel-Latif A; Lotfy A
    Stem Cell Res Ther; 2021 Aug; 12(1):469. PubMed ID: 34419143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of MSC Therapy in Attenuating the Damaging Effects of the Cytokine Storm Induced by COVID-19 on the Heart and Cardiovascular System.
    Ellison-Hughes GM; Colley L; O'Brien KA; Roberts KA; Agbaedeng TA; Ross MD
    Front Cardiovasc Med; 2020; 7():602183. PubMed ID: 33363221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. May mesenchymal stem cell transplantation be a solution for COVID-19 induced cytokine storm?
    Sütlüoğlu H; Özdemir Ö
    World J Transplant; 2021 Aug; 11(8):344-355. PubMed ID: 34447671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: Gleaning insights for possible use in COVID-19.
    Yen BL; Yen ML; Wang LT; Liu KJ; Sytwu HK
    Stem Cells Transl Med; 2020 Oct; 9(10):1163-1173. PubMed ID: 32526079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virology of SARS-CoV-2 and management of nCOVID-19 utilizing immunomodulation properties of human mesenchymal stem cells-a literature review.
    Sachdeva K; Kumar A; Mohanty S
    Stem Cell Investig; 2021; 8():23. PubMed ID: 34917676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.